EMA: Clinical Trials Information System designated as WHO primary registry
03/04/2025
Leggi
Type 1 diabetes TrialNet: leading the charge in disease prediction, prevention, and immunotherapeutic mechanistic understanding
Jacobsen LM, Felton JL, Nathan BM, et al.
Diabetes Care. 2025:dc242908.
Leggi
Diabetes and natural and man-made disasters: prevention, preparation, response and recovery
Boulton AJM, Jenkins AJ, Makkar B, et al.
Diabetologia. Pub. online 21 Apr 2025.
Leggi
Scaffold-free endocrine tissue engineering: role of islet organization and implications in type 1 diabetes
Bal T
BMC Endocr Disord. 2025;25(1):107.
Leggi
Impact of islet transplantation on diabetes complications and mortality in patients living with type 1 diabetes
Perrier Q, Jambon-Barbara C, Kessler L
Diabetes Care. 2025:dc250059.
Leggi
ISS linee guida – SNLG: la dieta mediterranea
Pub. online 11 Apr 2025.
Leggi
Multidimensional sleep health: definitions and implications for cardiometabolic health: a scientific statement from the American Heart Association
St-Onge MP, Aggarwal B, Fernandez-Mendoza J, et al.
Circ Cardiovasc Qual Outcomes. 2025:e000139.
Leggi
Screening for food insecurity: US Preventive Services Task Force recommendation statement
Nicholson WK, Silverstein M, Wong JB et al, US Preventive Services Task Force
JAMA. Pub. online 15 Apr 2025.
Leggi
Prevalence of hypercortisolism in difficult-to-control type 2 diabetes
Buse JB, Kahn SE, Aroda VR, et al.
Diabetes Care. 2025:dc242841.
Leggi
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
Grenet G, Gougeon A, Salzwedel DM, et al.
Cochrane Database Syst Rev. 2025;4(4):CD016144.
Leggi